NO941019L - Indolderivater for behandling av migrene - Google Patents

Indolderivater for behandling av migrene

Info

Publication number
NO941019L
NO941019L NO941019A NO941019A NO941019L NO 941019 L NO941019 L NO 941019L NO 941019 A NO941019 A NO 941019A NO 941019 A NO941019 A NO 941019A NO 941019 L NO941019 L NO 941019L
Authority
NO
Norway
Prior art keywords
image
alkyl group
migraine
treatment
indole derivatives
Prior art date
Application number
NO941019A
Other languages
English (en)
Other versions
NO941019D0 (no
NO180231C (no
NO180231B (no
Inventor
Doloers Fernandez Forner
Carles Puig Duran
Armando Vega Noverola
Jose Prieto Soto
Jacinto Moragues Mauri
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10719423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO941019(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of NO941019D0 publication Critical patent/NO941019D0/no
Publication of NO941019L publication Critical patent/NO941019L/no
Publication of NO180231B publication Critical patent/NO180231B/no
Publication of NO180231C publication Critical patent/NO180231C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processing Of Solid Wastes (AREA)
  • Fertilizers (AREA)
NO941019A 1992-07-28 1994-03-22 Indolderivater for behandling av migrene NO180231C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929216009A GB9216009D0 (en) 1992-07-28 1992-07-28 New indol derivatives
PCT/EP1993/001901 WO1994002460A1 (en) 1992-07-28 1993-07-19 Indol derivatives for the treatment of migraine

Publications (4)

Publication Number Publication Date
NO941019D0 NO941019D0 (no) 1994-03-22
NO941019L true NO941019L (no) 1994-03-22
NO180231B NO180231B (no) 1996-12-02
NO180231C NO180231C (no) 1997-03-12

Family

ID=10719423

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941019A NO180231C (no) 1992-07-28 1994-03-22 Indolderivater for behandling av migrene

Country Status (33)

Country Link
US (1) US5565447A (no)
EP (1) EP0605697B1 (no)
JP (1) JP2716585B2 (no)
KR (1) KR100191830B1 (no)
CN (1) CN1035179C (no)
AT (1) ATE177080T1 (no)
BR (2) BR9305589A (no)
CA (1) CA2120028C (no)
CZ (1) CZ282659B6 (no)
DE (2) DE69323712T2 (no)
DK (1) DK0605697T3 (no)
EC (1) ECSP930953A (no)
EG (1) EG20340A (no)
FI (1) FI109998B (no)
GB (1) GB9216009D0 (no)
GR (1) GR3029915T3 (no)
HK (1) HK1011680A1 (no)
HU (2) HUT70518A (no)
IL (1) IL106387A (no)
LU (1) LU90758I2 (no)
MX (1) MX9304524A (no)
MY (1) MY113266A (no)
NL (1) NL300053I2 (no)
NO (1) NO180231C (no)
NZ (1) NZ254152A (no)
PL (1) PL174352B1 (no)
RU (1) RU2117667C1 (no)
SG (1) SG48708A1 (no)
TW (1) TW235297B (no)
UA (1) UA27818C2 (no)
UY (1) UY23624A1 (no)
WO (1) WO1994002460A1 (no)
ZA (1) ZA935316B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712591B1 (fr) * 1993-11-19 1996-02-09 Pf Medicament Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
FR2731224B1 (fr) * 1995-03-02 1997-05-30 Pf Medicament Nouveaux derives bi-tryptaminiques sulfonamides, leur procede de preparation et leur utilisation a titre de medicaments
GB9523462D0 (en) * 1995-11-16 1996-01-17 Merck Sharp & Dohme Therapeutic agents
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6204274B1 (en) 1998-04-29 2001-03-20 American Home Products Corporation Indolyl derivatives as serotonergic agents
US6310066B1 (en) 1998-04-29 2001-10-30 American Home Products Corp. Antipsychotic indolyl derivatives
US6066637A (en) * 1998-06-19 2000-05-23 American Home Products Corporation Indolyl derivatives as serotonergic agents
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
WO2006129190A1 (en) * 2005-06-03 2006-12-07 Glenmark Pharmaceuticals Limited Process for the preparation of almotriptan
US20070112055A1 (en) * 2005-09-30 2007-05-17 Glenmark Pharmaceuticals Limited Crystalline forms of almotriptan and processes for their preparation
DE102006027229A1 (de) * 2006-06-09 2007-12-20 Grünenthal GmbH 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
ATE502921T1 (de) 2006-10-19 2011-04-15 Auspex Pharmaceuticals Inc Substituierte indole
TWI321616B (en) 2007-03-27 2010-03-11 Coretronic Corp Centrifugal blower
CZ302424B6 (cs) * 2007-06-13 2011-05-11 Zentiva, A. S. Zpusob prípravy almotriptanu o vysoké cistote
CN101842352A (zh) * 2007-08-02 2010-09-22 基因里克斯(英国)有限公司 新方法
CN103724252A (zh) * 2012-10-12 2014-04-16 苏州四同医药科技有限公司 一种阿莫曲坦的制备方法
EP3766483A1 (en) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Orodispersible powder composition comprising a triptan

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB2162532B (en) * 1984-08-04 1988-08-03 Ritchie Swanson John Decontaminant wash composition
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
AU646871B2 (en) * 1990-06-07 1994-03-10 Astrazeneca Uk Limited Therapeutic heterocyclic compounds

Also Published As

Publication number Publication date
DE10199016I1 (de) 2001-05-23
HU211243A9 (en) 1995-11-28
MX9304524A (es) 1994-04-29
NZ254152A (en) 1996-12-20
CA2120028C (en) 1999-03-23
ZA935316B (en) 1994-02-14
EP0605697A1 (en) 1994-07-13
NO941019D0 (no) 1994-03-22
EP0605697B1 (en) 1999-03-03
CA2120028A1 (en) 1994-02-03
TW235297B (no) 1994-12-01
MY113266A (en) 2002-01-31
NO180231C (no) 1997-03-12
UA27818C2 (uk) 2000-10-16
HK1011680A1 (en) 1999-07-16
US5565447A (en) 1996-10-15
FI109998B (fi) 2002-11-15
JP2716585B2 (ja) 1998-02-18
BR9305589A (pt) 1996-01-02
AU661190B2 (en) 1995-07-13
AU4570793A (en) 1994-02-14
RU2117667C1 (ru) 1998-08-20
CN1087629A (zh) 1994-06-08
JPH06511261A (ja) 1994-12-15
EG20340A (en) 1998-10-31
IL106387A (en) 1997-04-15
NL300053I2 (nl) 2002-04-02
DE69323712T2 (de) 1999-07-01
ECSP930953A (es) 1994-08-15
SG48708A1 (en) 1998-05-18
FI941413A0 (fi) 1994-03-25
DK0605697T3 (da) 1999-09-27
GB9216009D0 (en) 1992-09-09
DE10199016I2 (de) 2006-04-06
GR3029915T3 (en) 1999-07-30
LU90758I2 (fr) 2001-06-11
BR1100061A (pt) 2000-04-18
WO1994002460A1 (en) 1994-02-03
DE69323712D1 (de) 1999-04-08
KR100191830B1 (ko) 1999-06-15
PL174352B1 (pl) 1998-07-31
IL106387A0 (en) 1993-11-15
CZ282659B6 (cs) 1997-08-13
CZ66494A3 (en) 1994-12-15
HUT70518A (en) 1995-10-30
UY23624A1 (es) 1993-08-10
HU9400869D0 (en) 1994-06-28
NO180231B (no) 1996-12-02
NL300053I1 (nl) 2001-11-01
CN1035179C (zh) 1997-06-18
FI941413A (fi) 1994-03-25
PL302917A1 (en) 1994-09-05
ATE177080T1 (de) 1999-03-15

Similar Documents

Publication Publication Date Title
NO941019L (no) Indolderivater for behandling av migrene
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
FI891548A (fi) Administrering av monoaminakridiner i kolinergiska bristtillstaond av nervceller.
TR200100439T2 (tr) 1H-İmidazopiridin türevleri
ES2091615T3 (es) Derivados de indol fungicidas.
NZ225820A (en) Piperidyl substituted indole derivatives and pharmaceutical compositions
IE811831L (en) Indoles.
RU94020400A (ru) Производные индола, способ их получения, фармацевтическая композиция, способ лечения головной боли
DE69332945D1 (de) Indol-derivat, verfahren zu dessen herstellung und dessen medizinische anwendung
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
NO924166D0 (no) Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav
TW336232B (en) Indol-3-yl propenoic acid derivatives for antagonizing NMDA(N-methyl-D-aspartate) and pharmaceutical compositions thereof
ES2056025A1 (es) Nuevos derivados de indol.
EP0782988A4 (en) INDOL DERIVATIVES
TH15125EX (th) อนุพันธ์อินดอลชนิดใหม่
YU9893A (sr) Derivati indola

Legal Events

Date Code Title Description
MK1K Patent expired